Vancouver, British Columbia and Los Angeles, California – TheNewswire - (September 5, 2024) – Femto Technologies Inc., formerly known as BYND Cannasoft Enterprises Inc.  (Nasdaq: BCAN) (“Femto” or the “Company”), a leading innovator in the FemTech industry, has submitted its flagship feminine wellness product to the CES Innovation Awards competition, scheduled to be announced in January 2025. Femto’s groundbreaking product is set to redefine the standards of feminine care and wellness, showcasing its proprietary SRS (Smart Release System) technology, smart personalization technology, and futuristic machine learning and AI capabilities. Femto’s SRS technology utilizes advanced sensors that precisely detect, infuse, and personalize wellness substances, aiming to support feminine intimacy and wellbeing. Femto’s commitment to enhancing women’s health and wellbeing through cutting-edge technology is leading the Company’s innovation pipeline and growth route.

CES is the most powerful tech event in the world—the proving ground for breakthrough technologies and global innovators. The CES Innovation Awards annual competition celebrates outstanding design and engineering in consumer technology products. The program recognizes honorees in various categories, distinguishing the highest-rated products as ‘Best of Innovation’. Femto will be competing in the ‘Embedded Techbologies’ and ‘AI’ categories.

Femto has rapidly emerged as a pioneer in the FemTech sector, dedicated to addressing the unique health and wellness needs of women through innovative and scientifically backed solutions. The introduction of its flagship product marks a significant milestone in the company’s journey to empower women and improve their quality of life.

“We are thrilled to be evaluated by a panel of industry experts based on criteria, such as innovation, engineering, functionality, and aesthetics, all of which are key components in our product,” explained Yftah Ben Yaackov, CEO of Femto. “We value the opportunity to shine a light on the importance of women’s health, pleasure, and overall wellbeing and our commitment to improving technology-driven personalization for women.”

Key highlights of Femto’s flagship product include:

• Advanced Technology: Integrating the latest in FemTech innovation to provide superior wellness support. 

• User-Centric Design: Engineered to cater to the specific needs and preferences of women. 

• Holistic Wellness: Promoting overall wellbeing through comprehensive care solutions. 

Femto invites all attendees, media representatives, and industry professionals to visit their booth at the CES Expo to learn more about their pioneering product and explore the future of feminine wellness

For more information, visit www.femtocorp.com or reach out to schedule a demonstration at CES 2025.

About Femto Technologies Inc.

Femto, previously known as BYND Cannasoft Enterprises Inc., aims to become a leader of transformative change in the sphere of female health and wellness. Through proprietary Smart Release Technology and a dedication to creating smart, women-centric products, Femto is establishing new benchmarks in the wellness industry.

Femto is a British Columbia integrated software company based in Israel. Femto owns and markets "Benefit CRM", a proprietary customer relationship management (CRM) software product enabling small and medium‐sized businesses to optimize their day‐to‐day business activities such as sales management, personnel management, marketing, call center activities, and asset management.

Femto owns the patent-pending intellectual property for the EZ-G device. This therapeutic device uses proprietary software to regulate the flow of low concentrations of CBD oil, hemp seed oil, and other natural oils into the soft tissues of the female reproductive system to potentially treat a wide variety of women's health issues. The EZ-G device includes technological advancements as a sex toy with a more realistic experience and the prototype utilizes sensors to determine what enhances the user’s pleasure. The user can control the device through a Bluetooth app installed on a smartphone or other portable device. The data will be transmitted and received from the device to and from the secure cloud using artificial intelligence (AI). The data is combined with other antonymic user preferences to improve its operation by increasing sexual satisfaction. Commercialization of the EZ-G device is subject to regulatory approvals.

The devices described in this news release are concept devices that are in the first stage of development and will be subject to testing, experiments and regulatory approvals and therefore there is no certainty that they will eventually be marketed.

For further information please refer to the Company’s new website: www.femtocorp.com and on SEDAR+: www.sedarplus.ca.

Gabi Kabazo

Chief Financial Officer

Tel: (604) 833-6820

e‐mail: ir@femtocorp.com

Cautionary Note Regarding Forward-Looking Statements

This press release includes certain statements that may be deemed “forward-looking statements” within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended and under Canadian securities laws. When used in this press release, the words “may”, “would”, “could”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” and similar expressions are intended to identify forward‐looking statements. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements.

Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance, and actual events or developments may differ materially from those in forward-looking statements. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause the Company’s actual performance and financial results in future periods to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements. Such statements reflect the Company's current views with respect to future events and are subject to such risks and uncertainties. Many factors could cause actual results to differ materially from the statements made, including future financial performance, unanticipated regulatory requests and delays, final patents approval, and those factors discussed in filings made by the company with the Canadian securities regulatory authorities, including (without limitation) in the company's management's discussion and analysis for the year ended December 31, 2023 and annual information form dated April 2, 2024, which are available under the company's profile at www.sedarplus.ca, and in the Company’s Annual Report on Form 20-F for the year then ended that was filed with the U.S. Securities and Exchange Commission on April 3, 2024. Should one or more of these factors occur, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, or expected. We do not intend and do not assume any obligation to update these forward‐looking statements, except as required by law. Any such forward-looking statements represent management's estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. Shareholders are cautioned not to put undue reliance on such forward‐looking statements.